Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Sep 21, 2023

BUY
$43.41 - $56.51 $221,390 - $288,201
5,100 New
5,100 $287,000
Q4 2020

Feb 16, 2021

BUY
$43.41 - $56.51 $221,390 - $288,201
5,100 New
5,100 $287,000
Q3 2020

Nov 13, 2020

SELL
$47.43 - $60.75 $1.74 Million - $2.23 Million
-36,700 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $717,915 - $1.1 Million
16,500 Added 81.68%
36,700 $2.04 Million
Q2 2018

Aug 14, 2018

BUY
$48.15 - $56.68 $972,630 - $1.14 Million
20,200 New
20,200 $1.05 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.